New developments with vancomycin-resistant enterococci: E. faecium--friend or foe?
Bertics
Paul J
PJ
Wiepz
Gregory J
GJ
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002170:Canada / Q000453:epidemiology; D016984:Enterococcus faecium / Q000187:drug effects* / Q000276:immunology* / Q000302:isolation & purification; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology* / Q000382:microbiology; D006801:Humans; D007249:Inflammation / Q000517:prevention & control*; D014481:United States / Q000453:epidemiology; D014640:Vancomycin / Q000494:pharmacology*; D020713:Vancomycin Resistance
D000900:Anti-Bacterial Agents; D014640:Vancomycin